Taveras Arthur

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
5
Insider Sells Sum
$77,742.52

Insider Activity of Taveras Arthur

According to the SEC Form 4 filings, Taveras Arthur, being in a position of

  1. Chief Scientific Officer at X4 Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 82717 shares for $62,762,
    over all time since 2023-02-13, has bought 0 shares, and sold 100451 share for $77,743.

The largest sale of all time was on 2023-11-01 and amounted to 67695 shares of X4 Pharmaceuticals, Inc. for $49,417.

Biography of Taveras Arthur

No biography is available at this moment.

2024-03-11SaleX4 Pharmaceuticals, Inc.
XFOR
Chief Scientific Officer
14,235
0.0082%
$0.88$12,552+5.15%
2024-02-12SaleX4 Pharmaceuticals, Inc.
XFOR
Chief Scientific Officer
787
0.0005%
$1.01$793-7.39%
2023-11-01SaleX4 Pharmaceuticals, Inc.
XFOR
Chief Scientific Officer
67,695
0.0398%
$0.73$49,417+14.91%
2023-03-10SaleX4 Pharmaceuticals, Inc.
XFOR
Chief Scientific Officer
16,806
0.0109%
$0.84$14,117+9.67%
2023-02-13SaleX4 Pharmaceuticals, Inc.
XFOR
Chief Scientific Officer
928
0.0006%
$0.93$863+3.64%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.